{
  "ptid_time": "035_S_6306_2018-04-18",
  "img_path": "/data/qiuhui/data/adni/images/035_S_6306/2018-04-18/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 21,096 mm³, 45.2% below the reference mean. With a Z-score of -1.08 (13.9th percentile), this represents mild atrophy; hippocampal volume measures 9,185 mm³, 21.5% above the reference mean. With a Z-score of 2.10 (98.2th percentile), this represents significant enlargement; whole brain volume measures 1,229,990 mm³, 14.0% above the reference mean. With a Z-score of 1.81 (96.5th percentile), this represents moderate enlargement; entorhinal cortex volume measures 5,009 mm³, 22.2% above the reference mean. With a Z-score of 1.50 (93.3th percentile), this represents moderate enlargement; fusiform gyrus volume measures 20,886 mm³, 10.9% above the reference mean. With a Z-score of 0.93 (82.3th percentile), this represents normal volume ; middle temporal gyrus volume measures 27,189 mm³, 27.4% above the reference mean. With a Z-score of 2.46 (99.3th percentile), this represents significant enlargement. ",
  "text_data": "Age is 73.2 years. Gender is Male. Education: 14 years. Handedness: Right. Race: White. MMSE: 29.0. MoCA: 24.0. Logical Memory: 11.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.14 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mixed findings, with mild ventricular atrophy but significant enlargement in hippocampal, whole brain, entorhinal cortex, and middle temporal gyrus volumes. Cognitive scores are borderline (MMSE 29, MoCA 24), and APOE4 carrier status increases Alzheimer’s risk, but AV45 (amyloid PET) is normal.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)**  \n**Confidence:** **Medium** (due to conflicting imaging findings—atrophy vs. enlargement—and normal amyloid PET despite borderline cognitive scores).",
  "timestamp": "2025-07-26T05:59:48.684377"
}